Calcagno DQ, Leal MF, Assumpção PP, Smith MAC, Burbano RR. MYC and gastric adenocarcinoma carcinogenesis. World J Gastroenterol 2008; 14(39): 5962-5968 [PMID: 18932273 DOI: 10.3748/wjg.14.5962]
Corresponding Author of This Article
Rommel Rodríguez Burbano, Laboratório de Citogenética Humana, Departamento de Biologia, Instituto de Ciências Biológicas, Campus Universitário do Guamá/Universidade Federal do Pará, Av. Augusto Correa 01, Belém, PA 66075-900, Brazil. rommel@ufpa.br
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Oct 21, 2008; 14(39): 5962-5968 Published online Oct 21, 2008. doi: 10.3748/wjg.14.5962
MYC and gastric adenocarcinoma carcinogenesis
Danielle Queiroz Calcagno, Mariana Ferreira Leal, Paulo Pimentel Assumpção, Marília de Arruda Cardoso Smith, Rommel Rodríguez Burbano
Danielle Queiroz Calcagno, Rommel Rodríguez Burbano, Human Cytogenetics Laboratory, Biology Science Institute, Federal University of Pará, Belém PA 66075-900, Brazil
Mariana Ferreira Leal, Marília de Arruda Cardoso Smith, Genetics Division, Department of Morphology and Genetics, Federal University of São Paulo, São Paulo SP 04023-900, Brazil
Paulo Pimentel Assumpção, João de Barros Barreto University Hospital, Federal University of Pará, Belém PA 66073-000, Brazil
Author contributions: Calcagno DQ, Leal MF, Assumpção PP, Smith MAC and Burbano RR contributed equally to this work; the authors wrote the paper based on results of their own experience and recent literature sources (PubMed, ISI Web of Science) on gastric cancer.
Supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, DQC, MACS and RRB) and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, MFL)
Correspondence to: Rommel Rodríguez Burbano, Laboratório de Citogenética Humana, Departamento de Biologia, Instituto de Ciências Biológicas, Campus Universitário do Guamá/Universidade Federal do Pará, Av. Augusto Correa 01, Belém, PA 66075-900, Brazil. rommel@ufpa.br
Telephone: +55-91-32429254 Fax: +55-91-32111601
Received: April 10, 2008 Revised: June 7, 2008 Accepted: June 14, 2008 Published online: October 21, 2008
Abstract
MYC is an oncogene involved in cell cycle regulation, cell growth arrest, cell adhesion, metabolism, ribosome biogenesis, protein synthesis, and mitochondrial function. It has been described as a key element of several carcinogenesis processes in humans. Many studies have shown an association between MYC deregulation and gastric cancer. MYC deregulation is also seen in gastric preneoplastic lesions and thus it may have a role in early gastric carcinogenesis. Several studies have suggested that amplification is the main mechanism of MYC deregulation in gastric cancer. In the present review, we focus on the deregulation of the MYC oncogene in gastric adenocarcinoma carcinogenesis, including its association with Helicobacter pylori (H pylori) and clinical applications.
